➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Moodys
Colorcon
Baxter
Merck

Last Updated: June 19, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Kynurenic Acid


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Kynurenic Acid?

Kynurenic Acid is an investigational drug.

There have been 4 clinical trials for Kynurenic Acid. The most recent clinical trial was a Phase 1 trial, which was initiated on February 16th 2018.

The most common disease conditions in clinical trials are Schizophrenia, Neuralgia, and Inflammation. The leading clinical trial sponsors are University of Maryland, Hôpital Raymond Poincaré, and Hopital Lariboisière.

There are six hundred and fifty-six US patents protecting this investigational drug and four international patents.

Recent Clinical Trials for Kynurenic Acid
TitleSponsorPhase
The Effects of Kynurenine Aminotransferase Inhibition in People With SchizophreniaUniversity of MarylandPhase 1/Phase 2
Ketamine's Efficiency in the Treatment of Chronic Pain: Kynurenin PathwayFondation ApicilPhase 3
Ketamine's Efficiency in the Treatment of Chronic Pain: Kynurenin PathwayHopital LariboisièrePhase 3

See all Kynurenic Acid clinical trials

Clinical Trial Summary for Kynurenic Acid

Top disease conditions for Kynurenic Acid
Top clinical trial sponsors for Kynurenic Acid

See all Kynurenic Acid clinical trials

US Patents for Kynurenic Acid

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Kynurenic Acid   Get Started Free Biomarkers for differentiating between non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD) METANOMICS HEALTH GMBH (Berlin, DE) UNIVERSITATSKLINIKUM SCHLESWIG-HOLSTEIN (Kiel, DE)   Get Started Free
Kynurenic Acid   Get Started Free Methods and systems for metabolite and/or lipid-based detection of colorectal cancer and/or adenomatous polyps Universal Diagnostics, S. L. (Seville, ES)   Get Started Free
Kynurenic Acid   Get Started Free Amphiphilic compounds with neuroprotective properties USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I. (Praha, CZ) FYZIOLOGICKY USTAV AV CR, V.V.I. (Praha, CZ)   Get Started Free
Kynurenic Acid   Get Started Free Solution phase homogeneous assays Beckman Coulter, Inc. (Brea, CA)   Get Started Free
Kynurenic Acid   Get Started Free Pathway specific markers for diagnosing irritable bowel syndrome Nestec S.A. (Vevey, CH)   Get Started Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Kynurenic Acid

Drugname Country Document Number Estimated Expiration Related US Patent
Kynurenic Acid Australia AU2011273748 2030-06-10   Get Started Free
Kynurenic Acid Brazil BR112012031232 2030-06-10   Get Started Free
Kynurenic Acid Canada CA2799032 2030-06-10   Get Started Free
Kynurenic Acid European Patent Office EP2580596 2030-06-10   Get Started Free
Kynurenic Acid European Patent Office EP2863227 2030-06-10   Get Started Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
McKesson
Colorcon
Boehringer Ingelheim
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.